DalsnaFinance › IPOs › Cue Biopharma › IPO
Cue Biopharma, Inc. completed its initial public offering on NASDAQ on January 2, 2018, pricing at $7.50 a share.
| Ticker | CUE |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 2, 2018 |
| Offering price | $7.50 |
| Shares offered | 8,820,710 |
| Total raised | $66M |
Cue Biopharma, Inc. sold 8,820,710 shares at $7.50 each on NASDAQ. Multiplied out, that is $66.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $66 million total recorded for the deal.
Cue Biopharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Cue Biopharma, Inc.. This page is general information, not investment advice.